These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7575778)

  • 1. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus.
    Nomura S; Suzuki M; Katsura K; Xie GL; Miyazaki Y; Miyake T; Kido H; Kagawa H; Fukuhara S
    Atherosclerosis; 1995 Aug; 116(2):235-40. PubMed ID: 7575778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid beta-protein precursor-rich platelet microparticles in thrombotic disease.
    Nomura S; Komiyama Y; Miyake T; Miyazaki Y; Kido H; Suzuki M; Kagawa H; Yanabu M; Takahashi H; Fukuhara S
    Thromb Haemost; 1994 Oct; 72(4):519-22. PubMed ID: 7533336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated platelet and oxidized LDL induce endothelial membrane vesiculation: clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes.
    Nomura S; Shouzu A; Omoto S; Nishikawa M; Iwasaka T; Fukuhara S
    Clin Appl Thromb Hemost; 2004 Jul; 10(3):205-15. PubMed ID: 15247977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokines.
    Nomura S; Imamura A; Okuno M; Kamiyama Y; Fujimura Y; Ikeda Y; Fukuhara S
    Thromb Res; 2000 May; 98(4):257-68. PubMed ID: 10822072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy.
    Choudhury A; Chung I; Blann AD; Lip GYH
    Chest; 2007 Mar; 131(3):809-815. PubMed ID: 17356097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus.
    Nomura S; Kanazawa S; Fukuhara S
    J Diabetes Complications; 2003; 17(3):153-9. PubMed ID: 12738400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
    Tan KT; Tayebjee MH; Lim HS; Lip GY
    Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid risk factors in patients requiring arterial reconstruction.
    Seeger JM; Silverman SH; Flynn TC; Bailey JC; Klingman NV; Lawson GA; Borgeson MD; Barratt EJ
    J Vasc Surg; 1989 Oct; 10(4):418-24. PubMed ID: 2795767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of platelet specific proteins and other factors to atherosclerosis in various stages of hypertension.
    Ding YA; Chou TC; Huan R; Lin KC
    Clin Exp Hypertens A; 1991; 13(8):1329-41. PubMed ID: 1836985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
    Ravindran R; Krishnan LK
    Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous L-arginine and HDL can alter LDL and ox-LDL-mediated platelet activation: using platelet P-selectin receptor numbers.
    Sener A; Enc E; Ozsavci D; Vanizor-Kural B; Yanikkaya-Demirel G; Oba R; Uras F; Demir M
    Clin Appl Thromb Hemost; 2011; 17(6):E79-86. PubMed ID: 21078607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients.
    Csongrádi É; Nagy B; Fulop T; Varga Z; Karányi Z; Magyar MT; Oláh L; Papp M; Facskó A; Kappelmayer J; Paragh G; Káplár M
    Thromb Haemost; 2011 Oct; 106(4):683-92. PubMed ID: 21866298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
    Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
    Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus.
    Nomura S; Kanazawa S; Fukuhara S
    J Hum Hypertens; 2002 Aug; 16(8):539-47. PubMed ID: 12149659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of platelets by in vitro whole blood contact with materials: increases in microparticle, procoagulant activity, and soluble P-selectin blood levels.
    Gemmell CH
    J Biomater Sci Polym Ed; 2001; 12(8):933-43. PubMed ID: 11718486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of diabetes on platelet activation in different manifestations of atherosclerosis.
    Gremmel T; Kopp CW; Seidinger D; Koppensteiner R; Steiner S; Panzer S
    Swiss Med Wkly; 2013; 143():w13800. PubMed ID: 23740526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble P-selectin levels in diabetes mellitus patients with coronary artery disease.
    Aref S; Sakrana M; Hafez AA; Hamdy M
    Hematology; 2005 Jun; 10(3):183-7. PubMed ID: 16019467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis.
    Utsumi K; Kawabe M; Hirama A; Ueda K; Kamada Y; Arii K; Komaba Y; Katsura K; Iino Y; Katayama Y
    Clin Chim Acta; 2007 Feb; 377(1-2):198-200. PubMed ID: 17126824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of Pulsed Electric Field Conditions Results in Distinct Activation Profiles of Platelet-Rich Plasma.
    Frelinger AL; Gerrits AJ; Garner AL; Torres AS; Caiafa A; Morton CA; Berny-Lang MA; Carmichael SL; Neculaes VB; Michelson AD
    PLoS One; 2016; 11(8):e0160933. PubMed ID: 27556645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.